Page 13 - Lab Studies News Today

Turn to jason and talk about what is happening with the markets and the economy, today just very quickly dr. fauci said we may have some answers within two weeks. what do you think the level of confidence will be once we know more about the durability of vaccines. >> i think we will have more data in the next days to two to three weeks. there are very crucial lab studies involving the antibodies of vaccinated people that would be studied in the lab. observational studies looking at people who ha...

Delta-specific vaccine. they made a beta-specific vaccine. they were trialing those at various times during this pandemic. didnt end up needing them because the current vaccines were still effective against those strains, and that could happen here as well. so, you know, hate to be the person who echoes that "i dont know," but i think thats the most honest answer right now. once we get those lab studies and see clinical data in terms of hospitalizations around the world, well have a much better ...

Contagious. we dont know whether it causes severe disease or mild disease. thats going to take a little while to sort out, because its still early days. weve only really known about this for about naive days and a bunch of it has been our whole thanksgiving weekend talking to people in south africa trying to get all the information we could. will it turn out this is a virus for which our current vaccines dont provide protection? thats the big question. well know that in about two or three weeks....

Resources and energy towards those things. they are not in contradiction with each other. we have to identify this variant when it arrives in the u.s. if it isnt already here. we do need to start thinking about building a specific vaccine, not necessarily because we will need it. i dont know if we will need it. we shouldnt wait until all the facts are in. the urgency to vaccinate africa, that has been a huge issue for months. it has only gotten that much more acute. >> the white house is pointin...

A lot of that has not to do with vaccine supply, but hesitancy and the practice alities. we should all be able to look after our own populations as well as support the rollout of global vaccination by ensuring that theres enough vaccine being manufactured and that we do everything internationally to support the practicalities, the logistics of getting vaccines into peoples arms. >> in the meantime, were looking ahead to what vaccines we may potentially need for this omnicron variant. its unknowa...

This variant than weve seen in other viruses. some of those mutations are in regions of the virus that may impact transmissiblity and how they react with this virus. its really important not to get too excited about just the sequence data. we have to verify that in lab studies and i know there are labs around the world that are looking at antibodies that are induced from our vaccines to see how they neutralize or halt this virus. were looking at models and other data to see if these mutations wo...

The new variant in south africa is markedly different as we heard from the top of the show because it carries an unusual marker. sonoma county spoke with cardiologist about what sort of dangers this new variant could cause. take a listen. >> the big question now is will our immune response from vaccines or prior infections be blunted by this variant. if it proves to be one that interferes with our immune response, that isnt clear yet. those are the lab studies that have to be done in the days ah...

In the lab studies show vaccines may have certain mutations similar to the south african variant in the uk variant that makes vaccines a little bit weak and also shows potentially the monoclonal antibodies as we have may not be as effective but it is important to note this is only in the lab. we do not have evidence this is true in the real world, we dont have clinical evidence to show this, only the lab. sometimes what we see and do in the lab does not translate into the real world which is a g...

That variant a variant of interest and lab studies show it has the potential to be resistant to vaccines, although real world studies need to be conducted to confirm those findings. hallie? >> erin mclaughlin reporting in los angeles. dr. mercedes carnifhan of northwestern university feinberg school of medicine. thank you for being with us. good morning. >> thank you, hallie. i appreciate the invitation. >> of course, theres a whole bunch of topics to talk to you about today. president biden wil...

Place in the country. >> these covid variants follow the greek alphabet as you know, so the delta variant, and now the new mu variant, and how concerned should we be about that one? vaccine resistant, and what is known about it? >> okay. well, this is a variant of concern as labeled by the world health organization because it has some mutations that could potentially indicate some evasion of the immune response from vaccines, and also, you know, it could be more transmissible. now we have to rem...